Liposomes modified with P-aminophenyl-α-d-mannopyranoside: A carrier for targeting cerebral functional regions in mice

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 84, Issue 3, 2013, Pages 505-516

  Hao, Zhong Fei ^a   Cui, Yu Xia ^a   Li, Ming Hui ^a   Du, Dan ^a   Liu, Mei Fang ^a   Tao, Hai Quan ^a   Li, Sen ^a   Cao, Fang Yuan ^a   Chen, Ying Li ^a   Lei, Xu Hui ^a   Wang, Lin ^a   Zhu, Da Ling ^a   Peng, Hai Sheng ^a   Jiang, Chuan Lu ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Blood brain barrier; Functional regions; GLUT1; Liposomes modified with P aminophenyl d mannopyranoside; Targeting

Indexed keywords

CHOLESTEROL; DISTEAROYLPHOSPHATIDYLETHANOLAMINE; DRUG CARRIER; FLUORESCENT DYE; LIPOSOME; MACROGOL 2000; P AMINOPHENYL ALPHA DEXTRO MANNOPYRANOSIDE; PHENOBARBITAL; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PYRANOSIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BLOOD BRAIN BARRIER; BRAIN REGION; BRAIN STEM; CEREBELLUM; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG PENETRATION; DRUG TARGETING; DRUG TRANSPORT; DRUG UPTAKE; ELECTRIC RESISTANCE; EX VIVO STUDY; FLOW CYTOMETRY; FLUORESCENCE IMAGING; GLIOMA CELL; HIPPOCAMPUS; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR STABILITY; MOUSE; NEUROIMAGING; NONHUMAN; PONTINE NUCLEUS; WHOLE BODY IMAGING;

ANILINE COMPOUNDS; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CELL LINE, TUMOR; CELL NUCLEUS; CULTURE MEDIA; DRUG CARRIERS; ENDOCYTOSIS; FLOW CYTOMETRY; HIPPOCAMPUS; LIPOSOMES; MANNOSIDES; MICE; MICE, INBRED BALB C; RATS; TIME FACTORS;

EID: 84879071592     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2012.12.020     Document Type: Article

References (35)

1. X. Xu, A.E. Warrington, A.J. Bieber, and M. Rodriguez Enhancing CNS repair in neurological disease: challenges arising from neurodegeneration and rewiring of the network CNS Drugs 25 2011 555 573
2. H. Jeong Lee, and W.M. Pardridge Drug targeting to the brain using avidin-biotin technology in the mouse (blood-brain barrier, monoclonal antibody, transferrin receptor, Alzheimer's disease) J. Drug Target. 8 2000 413 424
3. W.M. Pardridge Blood-brain barrier delivery Drug Discov. Today 12 2007 54 61
4. Y. Chen, G. Dalwadi, and H.A. Benson Drug delivery across the blood-brain barrier Curr. Drug Deliv. 1 2004 361 376
5. M.Y. Chen, A. Hoffer, P.F. Morrison, J.F. Hamilton, J. Hughes, K.S. Schlageter, J. Lee, B.R. Kelly, and E.H. Oldfield Surface properties, more than size, limiting convective distribution of virus-sized particles and viruses in the central nervous system J. Neurosurg. 103 2005 311 319
6. S.S. Chiu, E. Lui, M. Majeed, J.K. Vishwanatha, A.P. Ranjan, A. Maitra, D. Pramanik, J.A. Smith, and L. Helson Differential distribution of intravenous curcumin formulations in the rat brain Anticancer Res. 31 2011 907 911
7. X. Ying, H. Wen, W.L. Lu, J. Du, J. Guo, W. Tian, Y. Men, Y. Zhang, R.J. Li, T.Y. Yang, D.W. Shang, J.N. Lou, L.R. Zhang, and Q. Zhang Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals J. Control. Release 141 2010 183 192
8. S. Sarkar, and N. Das Mannosylated liposomal flavonoid in combating age-related ischemia-reperfusion induced oxidative damage in rat brain Mech. Age. Dev. 127 2006 391 397
9. T. Nishioka, Y. Oda, Y. Seino, T. Yamamoto, N. Inagaki, H. Yano, H. Imura, R. Shigemoto, and H. Kikuchi Distribution of the glucose transporters in human brain tumors Cancer Res. 52 1992 3972 3979
10. K. Zeller, S. Rahner-Welsch, and W. Kuschinsky Distribution of Glut1 glucose transporters in different brain structures compared to glucose utilization and capillary density of adult rat brains J. Cereb. Blood Flow 17 1997 204 209
11. S.J. Vannucci, F. Maher, and I.A. Simpson Glucose transporter proteins in brain: delivery of glucose to neurons and glia Glia 21 1997 2 21
12. A.M. Brant, T.J. Jess, G. Milligan, C.M. Brown, and G.W. Gould Immunological analysis of glucose transporters expressed in different regions of the rat brain and central nervous system Biochem. Biophys. Res. Commun. 192 1997 1297 1302
13. C.C. Liu, Z. Shen, H.F. Kung, and M.C. Lin Cancer gene therapy targeting angiogenesis: an updated review World J. Gastroenterol. 12 2006 6941 6948
14. M. Mitra, A.K. Mandal, T.K. Chatterjee, and N. Das Targeting of mannosylated liposome incorporated benzyl derivative of Penicillium nigricans derived compound MT81 to reticuloendothelial systems for the treatment of visceral leishmaniasis J. Drug Target. 13 2005 285 293
15. T. Koto, K. Takubo, S. Ishida, H. Shinoda, M. Inoue, K. Tsubota, Y. Okada, and E. Ikeda Hypoxia disrupts the barrier function of neural blood vessels through changes in the expression of claudin-5 in endothelial cells Am. J. Pathol. 170 2007 1389 1397
16. G. Li, M.J. Simon, L.M. Cancel, Z.D. Shi, X. Ji, J.M. Tarbell, B. Morrison 3rd, and B.M. Fu Permeability of endothelial and astrocyte cocultures: in vitro blood-brain barrier models for drug delivery studies Ann. Biomed. Eng. 38 2010 2499 2511
17. A. Beduneau, F. Hindre, A. Clavreul, J.C. Leroux, P. Saulnier, and J.P. Benoit Brain targeting using novel lipid nanovectors J. Control. Release 126 2008 44 49
18. W. Pham, B.Q. Zhao, E.H. Lo, Z. Medarova, B. Rosen, and A. Moore Crossing the blood-brain barrier: a potential application of myristoylated polyarginine for in vivo neuroimaging NeuroImage 28 2005 287 292
19. Y. Qin, H. Chen, W. Yuan, R. Kuai, Q. Zhang, F. Xie, L. Zhang, Z. Zhang, J. Liu, and Q. He Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery Int. J. Pharm. 419 2011 85 95
20. S.D. Li, and L. Huang Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting J. Control. Release 145 2010 178 181
21. K. Doi, N. Oku, T. Toyota, S. Shuto, A. Sakai, H. Itoh, and S. Okada Therapeutic effect of reticuloendothelial system (RES)-avoiding liposomes containing a phospholipid analogue of 5-fluorouracil, dipalmitoylphosphatidylfluorouridine, in Meth A sarcoma-bearing mice Biol. Pharm. Bull. 17 1994 1414 1416
22. I.P. Kaur, R. Bhandari, S. Bhandari, and V. Kakkar Potential of solid lipid nanoparticles in brain targeting J. Control. Release 127 2008 97 109
23. K. Hu, J. Li, Y. Shen, W. Lu, X. Gao, Q. Zhang, and X. Jiang Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations J. Control. Release 134 2009 55 61
24. A.P. Dick, S.I. Harik, A. Klip, and D.M. Walker Identification and characterization of the glucose transporter of the blood-brain barrier by cytochalasin B binding and immunological reactivity Proc. Natl. Acad. Sci. 81 1984 7233 7237
25. L. Lu, A. Lundqvist, C.M. Zeng, C. Lagerquist, and P. Lundahl d-glucose, forskolin and cytochalasin B affinities for the glucose transporter Glut1. Study of pH and reconstitution effects by biomembrane affinity chromatography J. Chromatogr. A 776 1997 81 86
26. J. Klepper, J. Fischbarg, J.C. Vera, D. Wang, and D.C. De Vivo GLUT1-deficiency: barbiturates potentiate haploinsufficiency in vitro Pediatr. Res. 46 1999 677 683
27. A.G. de Boer, and P.J. Gaillard Drug targeting to the brain Annu. Rev. Pharmacol. 47 2007 323 355
28. I. van Rooy, S. Cakir-Tascioglu, W.E. Hennink, G. Storm, R.M. Schiffelers, and E. Mastrobattista In vivo methods to study uptake of nanoparticles into the brain Pharm. Res. 28 2011 456 471
29. S. Nagamatsu, Y. Nakamichi, N. Inoue, M. Inoue, H. Nishino, and H. Sawa Rat C6 glioma cell growth is related to glucose transport and metabolism Biochem. J. 319 Pt 2 1996 477 482
30. A. Sakamoto, and T. Ido Liposome targeting to rat brain: effect of osmotic opening of the blood-brain barrier Brain Res. 629 1993 171 175
31. V. Ntziachristos, C. Bremer, and R. Weissleder Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging Eur. Radiol. 13 2003 195 208
32. E. Lagrue, H. Abe, M. Lavanya, J. Touhami, S. Bodard, S. Chalon, J.L. Battini, M. Sitbon, and P. Castelnau Regional characterization of energy metabolism in the brain of normal and MPTP-intoxicated mice using new markers of glucose and phosphate transport J. Biomed. Sci. 17 2010 91
33. H. Yano, Y. Seino, N. Inagaki, Y. Hinokio, T. Yamamoto, K. Yasuda, K. Masuda, Y. Someya, and H. Imura Tissue distribution and species difference of the brain type glucose transporter (GLUT3) Biochem. Biophys. Res. Commun. 174 1991 470 477
34. F. Maher, S.J. Vannucci, and I.A. Simpson Glucose transporter proteins in brain FASEB J. 8 1994 1003 1011
35. S. Nagamatsu, J.M. Kornhauser, C.F. Burant, S. Seino, K.E. Mayo, and G.I. Bell Glucose transporter expression in brain. cDNA sequence of mouse GLUT3, the brain facilitative glucose transporter isoform, and identification of sites of expression by in situ hybridization J. Biol. Chem. 267 1992 467 472